September 01, 2002 article Open access Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab Blood DOI: 10.1182/blood.v100.5.1715.h81702001715_1715_1720 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 137 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia 2024 Journal of Allergy and Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 30 citations Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study 2023 Blood Advances article Medicine Hematopoietic Stem Cell Transplantation Open access 19 citations Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma 2022 Therapeutic Drug Monitoring article Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access 7 citations 3 results References 0